Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis

AIM: Three weeks paclitaxel and carboplatin has been considered the standard of care for primary treatment of ovarian cancer (OC). Whether weekly therapy will further improve the clinical outcomes or not is still unclear. We conducted a meta-analysis to compare the two regimens. METHOD: Articles wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Claudia, De Felice, Francesca, Musella, Angela, Palaia, Innocenza, Monti, Marco, Musio, Daniela, Muzii, Ludovico, Tombolini, Vincenzo, Panici, Pierluigi Benedetti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295464/
https://www.ncbi.nlm.nih.gov/pubmed/27509061
http://dx.doi.org/10.18632/oncotarget.11094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295464/
https://www.ncbi.nlm.nih.gov/pubmed/27509061
http://dx.doi.org/10.18632/oncotarget.11094

Ejemplares similares